Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Deficit (Tables)

v3.22.2.2
Shareholders' Deficit (Tables)
 6 Months Ended
Jun. 30, 2022
Stockholders' Equity Note [Abstract]  
Schedule of activity related to non-vested shares
    Number of
Non-Vested
Shares		     Weighted
Average
Grant Date
Fair Value		  
Non-vested, December 31, 2021     14,270,120     $ 0.14  
Granted     500,000       0.028  
Forfeited    
-
      
-
  
Shares vested     (800,000 )     (0.028 )
Non-vested, June 30, 2022     13,970,120     $ 0.14  

 
Schedule of stock option activities
    Number of
Options		     Weighted
Average
Exercise
Price		     Weighted
Average
Remaining
Contractual
Term (Years)		     Aggregate
Intrinsic
Value		  
Balance Outstanding, December 31, 2021     8,445,698     $ 0.40                           
Exercised    
-
      
-
      
-
      
-
  
Balance Outstanding, June 30, 2022     8,445,698     $ 0.40       3.94     $ 0  
Exercisable, June 30, 2022     8,445,698     $ 0.40       3.94     $ 0  

 
Schedule of warrant activities
    Number of
Warrants		     Weighted
Average
Exercise
Price		     Weighted
Average
Remaining
Contractual
Term (Years)		   Aggregate
Intrinsic
Value		  
Balance Outstanding December 31, 2021     17,500,000     $ 0.05       4.67   $
      -
  
Granted     33,000,000       0.025      
-
    
-
  
Cancelled     (16,500,000 )     0.05      
-
    
-
  
Balance Outstanding June 30, 2022     34,000,000     $ 0.027       4.24   $
-
  
Exercisable, June 30, 2022     34,000,000     $ 0.027       4.24   $
-